Felix Arellano
Global Head of Drug Safety – Roche

‘From Planning to Launch: How to Implement a New Safety Database and Maximize ROI’

Hans van Leeuwen
Global Head of Regulatory Operations – Astellas

‘Achieving Interoperable Safety and Regulatory Platforms’

Julie Thomas
Vice President, Global Medical Safety Operations – Johnson & Johnson

‘LifeSphere NavaX: Driving Greater Value with GenAI’

What to Expect and What’s Trending in Regulatory Affairs

In the rapidly evolving landscape of regulatory affairs, significant advancements and trends are shaping the future. At ArisGlobal, we're committed to staying at the forefront of these changes and ensuring our clients are well-prepared. Here's a deep dive into the latest developments and what to expect in the coming years. 

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

Follow Us

© 2024 ArisGlobal – All Rights Reserved